Redpoint Investment Management Pty LTD Biomarin Pharmaceutical Inc Transaction History

Redpoint Investment Management Pty LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$71.48 - $86.85 $356,327 - $432,947	-4,985 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$74.28 - $92.69 $29,266 - $36,519	394 Added 8.58%	4,985 $384,000
Q3 2020 Oct 09, 2020	SELL	$71.87 - $131.03 $26,304 - $47,956	-366 Reduced 7.38%	4,591 $349,000
Q2 2020 Jul 17, 2020	BUY	$79.55 - $124.22 $94,028 - $146,828	1,182 Added 31.31%	4,957 $611,000
Q3 2019 Nov 26, 2019	BUY	$67.4 - $85.11 $43,270 - $54,640	642 Added 20.49%	3,775 $254,000
Q4 2017 Aug 09, 2018	BUY	$80.76 - $95.13 $253,021 - $298,042	3,133	3,133 $279,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.